{
  "id": 11172905,
  "title": "Lilly’s Foundayo shows reduced diabetes, heart disease risk",
  "url": "https://urgent.news/2026/10/01/lillys-foundayo-shows-reduced-diabetes-heart-disease-risk",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-01T11:04:34.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/lillys-foundayo-shows-reduced-diabetes-heart-disease-risk-93CH-4927076"
  },
  "original_language": "en",
  "account": null,
  "summary": "Eli Lilly and Company's post-hoc analyses of its ATTAIN-1 trial have revealed promising results for its diabetes and cardiovascular disease risk-reducing medication, Foundayo. The Phase 3 trial, which involved 3,127 participants, demonstrated that Foundayo significantly reduced the predicted 10-year risk of type 2 diabetes and cardiovascular disease in adults with obesity or overweight with weight-related medical conditions. At 72 weeks, participants taking the 17.2 mg dose of Foundayo showed a 57% reduction in predicted type 2 diabetes risk and an 18% reduction in predicted cardiovascular disease risk compared to placebo. Lower doses of Foundayo also showed reductions in predicted type 2 diabetes risk, with the 9 mg and 5.5 mg doses showing 50% and 45% reductions, respectively. The findings were published in Diabetes, Obesity and Metabolism and were based on risk assessments using the Cardiometabolic Disease Staging risk engine for type 2 diabetes and the BMI-based Framingham risk engine for cardiovascular disease.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Seeking Alpha News",
        "title": "Lilly Foundayo is predicted to cut diabetes risk by 57% in late-stage study",
        "url": "https://urgent.news/2026/10/01/lilly-foundayo-is-predicted-to-cut-diabetes-risk-by-57-in-late-stage",
        "published": "2026-10-01T11:37:04.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}